It was reported that PPAR-γ activation can modulate inflammatory responses and inhibit the development and progression of a wide range of epithelial-derived human cancer cells, including prostate, breast, and colon cancers [12]–[14]. This evidence concerns the gene PPARG and colonic neoplasm.